Body-Mass Index and Mortality in Korean Men and Women by �삤�씗泥� & 吏��꽑�븯
T h e  n e w  e ng l a nd  j o u r na l  o f  m e dic i n e
n engl j med 355;8 www.nejm.org august 24, 2006 779
original article
Body-Mass Index and Mortality 
in Korean Men and Women
Sun Ha Jee, Ph.D., Jae Woong Sull, Ph.D., Jungyong Park, Ph.D., 
Sang-Yi Lee, M.D., Heechoul Ohrr, M.D., Eliseo Guallar, M.D., Dr.P.H., 
and Jonathan M. Samet, M.D.
From the Department of Epidemiology 
and Health Promotion, Graduate School 
of Public Health, Yonsei University, 
Seoul (S.H.J., J.P.); the National Health 
Insurance Corporation, Seoul (S.-Y.L.); 
the Department of Health Policy and 
Management, College of Medicine, Cheju 
National University, Jeju (S.-Y.L.); the 
Department of Preventive Medicine and 
Public Health, Yonsei University College 
of Medicine, Seoul (H.O.) — all in Korea; 
and the Department of Epidemiology, 
Johns Hopkins Bloomberg School of 
Public Health, Baltimore (S.H.J., J.W.S., 
E.G., J.M.S.). Address reprint requests to 
Dr. Jee at the Department of Epidemiology 
and Health Promotion, Graduate School 
of Public Health, Yonsei University, Seoul, 
Korea, or at jsunha@yumc.yonsei.ac.kr.
N Engl J Med 2006;355:779-87.
Copyright © 2006 Massachusetts Medical Society.
A BS TR AC T
Background
Obesity is associated with diverse health risks, but the role of body weight as a risk 
factor for death remains controversial.
Methods
We examined the association between body weight and the risk of death in a 12-
year prospective cohort study of 1,213,829 Koreans between the ages of 30 and 95 
years. We examined 82,372 deaths from any cause and 48,731 deaths from specific 
diseases (including 29,123 from cancer, 16,426 from atherosclerotic cardiovascular 
disease, and 3362 from respiratory disease) in relation to the body-mass index 
(BMI) (the weight in kilograms divided by the square of the height in meters).
Results
In both sexes, the average baseline BMI was 23.2, and the rate of death from any 
cause had a J-shaped association with the BMI, regardless of cigarette-smoking his-
tory. The risk of death from any cause was lowest among patients with a BMI of 23.0 
to 24.9. In all groups, the risk of death from respiratory causes was higher among 
subjects with a lower BMI, and the risk of death from atherosclerotic cardiovascular 
disease or cancer was higher among subjects with a higher BMI. The relative risk 
of death associated with BMI declined with increasing age.
Conclusions
Underweight, overweight, and obese men and women had higher rates of death 
than men and women of normal weight. The association of BMI with death varied 
according to the cause of death and was modified by age, sex, and smoking history.
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A lthough obesity is widely accepted as an important health risk, the optimal body-mass index (BMI) (the weight in kilo-
grams divided by the square of the height in me-
ters) and the effects of being either underweight 
or overweight on the risk of death are controver-
sial. In the Cancer Prevention Study (CPS) II,1 spon-
sored by the American Cancer Society, the rate of 
death was lowest among men with a BMI of 23.5 
to 24.9 and among women with a BMI of 22.0 to 
23.4; above and below these levels, the risk of 
death increased. However, being overweight was 
not associated with an increased risk of death in 
the National Health and Nutrition Examination 
Survey (NHANES) I, II, or III.2 The results of other 
studies have been mixed3,4 and may reflect dif-
ferences in age, the number or extent of coexisting 
illnesses, and BMI distributions among subjects, 
as well as in analytic approaches.1,5
Since studies of the association between BMI 
and death have been conducted primarily in West-
ern populations, it is uncertain whether the find-
ings of these studies can be applied to other 
groups. Continental Asian populations have a 
higher percentage of body fat for a given BMI 
than do whites,6 and a World Health Organization 
(WHO) Expert Consultation proposed a new BMI 
cutoff of 23.0 for public health action in Asia.7 
The use of this cutoff, however, was not directly 
supported by data on mortality.8,9 Indeed, deaths 
from any cause were lowest among men with a 
BMI of 24.0 to 24.9 and women with a BMI of 
25.0 to 26.9 in a representative group of Chinese 
subjects.10,11
We conducted a prospective cohort study of BMI 
and the risk of death from any cause and from 
specific diseases in more than 1 million Koreans 
in the Korean Cancer Prevention Study (KCPS).12,13
Me thods
Study Population
We enrolled 1,329,525 Koreans between the ages 
of 30 and 95 years who had undergone one bien-
nial medical evaluation through the National Health 
Insurance Corporation between 1992 and 1995.12,13 
Of the subjects, 784,870 (59.0 percent) were en-
rolled in 1992, 367,903 (27.7 percent) in 1993, 
98,417 (7.4 percent) in 1994, and 78,335 (5.9 per-
cent) in 1995.
To avoid confounding of the association be-
tween BMI and the risk of death by preexisting 
disease,14,15 904 subjects who died before Janu-
ary 1, 1993, were excluded from the study, as were 
87,911 subjects who reported having atheroscle-
rotic cardiovascular disease, cancer, liver disease, 
diabetes, or a respiratory disease at or before the 
initial study visit. In addition, 26,881 subjects with 
missing information about BMI or alcohol intake 
and those with an extremely low BMI (less than 
16.0) or short stature (1.30 m or less) were excluded. 
The final sample included 1,213,829 subjects.
Because the study involved data that were rou-
tinely collected, consent was not specifically ob-
tained. The institutional review boards of Yonsei 
University and the Johns Hopkins Bloomberg 
School of Public Health approved the study.
Data Collection
Enrollees in the National Health Insurance Cor-
poration undergo standardized examinations ev-
ery two years at local hospitals. During visits be-
tween 1992 and 1995, subjects reported on their 
smoking habits and alcohol consumption, and 
weight and height measurements were recorded 
while subjects were wearing light clothing. Sub-
jects were seated for blood-pressure measurement. 
Blood samples were obtained after an overnight 
fast for white-cell counts and clinical chemical 
analysis. Quality-control procedures were per-
formed in accordance with the Korean Associa-
tion of Laboratory Quality Control.
Follow-up and Outcome Classification
Deaths among subjects through December 31, 
2004, were confirmed by matching the informa-
tion to death records. Death certificates from the 
National Statistical Office were identified with 
the use of identification numbers assigned to sub-
jects at birth. Abstractors coded causes of death 
according to the International Classification of Dis-
eases, 10th Revision.16 We used underlying causes as 
reported.
We attempted to minimize the effect of exist-
ing medical conditions on the baseline BMI by 
excluding all events that occurred among subjects 
during the first two years of follow-up. Thus, gen-
eral follow-up began on January 1 of the third 
year after the baseline visit. In a sensitivity analy-
sis, we excluded the first five years of follow-up.
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Statistical Analysis
Proportional-hazards models were used to evalu-
ate the association between the baseline BMI and 
death.17 The BMI was categorized as less than 18.5, 
18.5 to 19.9, 20.0 to 21.4, 21.5 to 22.9, 23.0 to 24.9, 
25.0 to 26.4, 26.5 to 27.9, 28.0 to 29.9, 30 to 31.9, 
or 32.0 or more. Analyses were performed sepa-
rately in men and women and were adjusted for 
the following covariates: age at enrollment (con-
tinuous variable), alcohol intake (five categories 
based on grams consumed per day: 0, 1 to 24 g, 
25 to 49 g, 50 to 99 g, and 100 g or more), and 
participation in regular physical activity (yes or 
no). Because the proportion of women who report-
ed having smoked cigarettes was small, analyses 
in women were restricted to those who reported 
never having smoked. Analyses of men who re-
ported having smoked were adjusted for smoking 
status (never smoked, former smoker, or current 
smoker) and the number of cigarettes smoked dai-
ly among current smokers (1 to 9, 10 to 19, and 
20 or more).
Modification of the effect of BMI was assessed 
by the inclusion of interaction terms of BMI cate-
gory indicators with indicator variables for sex, 
age (three categories), and smoking history (two 
Table 1. Baseline Characteristics of the Study Population.*
Characteristic
Men
(N = 770,556)
Women
(N = 443,273)
Age — yr 45.0±11.1 49.4±12.1
BMI 23.2±2.6 23.2±3.1
Systolic blood pressure — mm Hg 124.5±16.0 121.5±19.1
Fasting serum glucose — mg/dl 92.1±23.1 89.9±22.4
Total serum cholesterol — mg/dl 191.1±37.7 194.4±39.3
Aspartate aminotransferase — 
U/liter
26.3±16.6 22.4±10.0
Alcoholic drinks — g per day 17.2±32.2 0.2±1.9
Smoking status — %
Never smoked 20.8 93.8
Former smoker 20.1 2.0
Current smoker 59.1 4.1
Any alcohol use — % 76.8 14.3
Physical activity — % 28.6 16.6
* Data are from the KCPS, 1992–1995.12,13 Plus–minus values are means ±SD. 
Percentages may not total 100 because of rounding. To convert the values for 
cholesterol to millimoles per liter, multiply by 0.02586. To convert the values 
for glucose to millimoles per liter, multiply by 0.05551.
Table 2. Differences in Baseline Systolic Blood Pressure and Clinical Chemical Analyses, According to BMI.*
BMI Men Women
Systolic Blood 
Pressure
Total 
Cholesterol
Fasting Serum 
Glucose
White-Cell 
Count
Systolic Blood 
Pressure 
Total 
Cholesterol
Fasting Serum 
Glucose
White-Cell 
Count
mm Hg mg/dl cells/mm3 mm Hg mg/dl cells/mm3
<18.5 −8.1 −19.9 −4.0 −94 −6.2 −14.3 −3.2 −360
18.5–19.9 −5.9 −15.8 −3.3 −143 −4.8 −10.9 −2.7 −350
20.0–21.4 −4.0 −11.4 −2.4 −97 −3.8 −8.0 −2.2 −266
21.5–22.9 −2.2 −5.9 −1.2 −56 −2.2 −4.4 −1.3 −138
23.0–24.9† 0 0 0 0 0 0  0 0
25.0–26.4 2.0 4.5 1.0 56 2.6 3.7 1.2 137
26.5–27.9 3.9 7.1 2.0 120 4.7 6.2 2.2 215
28.0–29.9 6.2 9.3 3.2 129 6.9 7.3 3.3 320
30.0–31.9 8.2 11.2 4.9 151 9.9 9.7 4.7 440
≥32.0 11.5 13.3 7.8 99 12.4 10.3 6.4 649
* Data are from the KCPS, 1992–1995.12,13 The reference category was a BMI of 23.0 to 24.9. All differences were adjusted for age (continu-
ous). To convert the values for cholesterol to millimoles per liter, multiply by 0.02586. To convert the values for glucose to millimoles per 
liter, multiply by 0.05551.
† This group served as the reference group.
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categories, one consisting of current and former 
smokers and one of lifetime nonsmokers). All 
analyses were conducted with the use of SAS soft-
ware, version 9 (SAS Institute).
R esult s
The average BMI was 23.2 for both sexes (Table 1), 
and the majority of subjects had a BMI below 
25.0. The BMI was below 18.5 in 2.2 percent of 
men and 4.7 percent of women; above 25.0 in 23.8 
percent and 26.8 percent, respectively; and above 
30.0 in 0.8 percent and 2.4 percent, respectively. 
Systolic blood pressure, total serum cholesterol, 
fasting serum glucose level, and white-cell count 
had strong, progressive associations with increas-
ing BMIs (Table 2).
During follow-up, 58,312 men died (including 
22,249 from cancer, 10,486 from atherosclerotic 
cardiovascular causes, and 2442 from respiratory 
causes) and 24,060 women died (including 6874 
from cancer, 5940 from atherosclerotic cardio-
vascular causes, and 920 from respiratory causes). 
The shape of the curve showing the association 
between BMI and the risk of death from any cause 
was similar in men, regardless of their smoking 
history, and in women who reported never hav-
ing smoked (Fig. 1A). The hazard ratio was higher 
at the lowest and highest BMI values.
Men with a BMI of 23.0 to 24.9 who reported 
never having smoked had the lowest risk of death 
from any cause (Table 1 of the Supplementary Ap-
pendix, available with the full text of this article 
at www.nejm.org). As compared with men with 
a BMI of 23.0 to 24.9, men who reported never 
having smoked had a hazard ratio for death 
from any cause of 1.29 (95 percent confidence 
interval, 1.15 to 1.44) in association with a BMI 
of less than 18.5, a hazard ratio of 1.04 (95 per-
cent confidence interval, 0.98 to 1.10) in asso-
ciation with a BMI of 25.0 to 29.9, and a hazard 
ratio of 1.71 (95 percent confidence interval, 
1.44 to 2.03) in association with a BMI of 30.0 
or more. As compared with men with a BMI of 
23.0 to 24.9, men who reported having smoked 
had a hazard ratio for death from any cause of 
1.36 (95 percent confidence interval, 1.30 to 1.42) 
in association with a BMI of less than 18.5, a 
hazard ratio of 0.98 (95 percent confidence in-
terval, 0.95 to 1.01) in association with a BMI of 
25.0 to 29.9, and a hazard ratio of 1.31 (95 percent 
confidence interval, 1.18 to 1.45) in association 
with a BMI of 30.0 or more.
Among women (with the analysis restricted 
to those who reported never having smoked), the 
risk of death from any cause was lowest for those 
with a BMI of 23.0 to 24.9 and similar for those 
with a BMI of 20.0 to 26.4 (Fig. 1A, and Table 2 
of the Supplementary Appendix). As compared 
with women with a BMI of 23.0 to 24.9, women 
with a BMI of less than 18.5 had a hazard ratio 
for death from any cause of 1.17 (95 percent con-
fidence interval, 1.09 to 1.26), women with a 
BMI of 25.0 to 29.9 had a hazard ratio of 1.04 
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Figure 1. Hazard Ratios for Death from Any Cause and from Any Cause Except Respiratory, According to BMI and Smoking History.
Data are from the KCPS, 1993–2004.12,13 The reference category was a BMI of 23.0 to 24.9. Results for men who reported having smoked 
cigarettes were further adjusted for whether the subject was a former smoker or a current smoker and the number of cigarettes smoked 
per day (1 to 9, 10 to 19, and 20 or more). All hazard ratios were adjusted for age.
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(95 percent confidence interval, 1.00 to 1.08), and 
women with a BMI of 30.0 or more had a hazard 
ratio of 1.20 (95 percent confidence interval, 
1.10 to 1.30).
The association between BMI and the risk of 
death according to the cause of death had a simi-
lar pattern of variation for both sexes (Fig. 2, 
and Tables 1 and 2 of the Supplementary Ap-
pendix). The risk of death from respiratory causes 
decreased progressively with increasing BMI, 
whereas the risk of death from atherosclerotic 
cardiovascular causes increased steadily with in-
creasing BMI. The risk of death from cancer in-
creased at a BMI above 26.0 to 28.0. Deaths from 
respiratory causes explained some of the increase 
in the risk of death at a low BMI (Fig. 1B). For 
deaths associated with lung disease, the associa-
tion between BMI and the risk of death was simi-
lar for the major categories of pulmonary illness-
es, including tuberculosis, chronic obstructive 
pulmonary disease (COPD), asthma, and pneumo-
nia; the association persisted after the exclusion 
of the first five years of follow-up. With this exclu-
sion, the hazard ratio for death from respiratory 
causes that was associated with a decrease in 
BMI of 1.0 was 1.26 (95 percent confidence in-
terval, 1.20 to 1.31) among men who reported 
never having smoked, 1.25 (95 percent confidence 
interval, 1.22 to 1.27) among men who reported 
having smoked, and 1.08 (95 percent confidence 
interval, 1.05 to 1.12) among women.
The relative increase in the risk of death from 
any cause that was associated with a high BMI 
was dependent on age (Fig. 3). For both sexes, 
the highest relative risks associated with a high 
BMI were observed among subjects younger than 
50 years of age. An increase in BMI to more than 
25.0 was not associated with an increased risk of 
death from any cause among men or women who 
were 65 years or older at baseline. The interaction 
between BMI and age was significant (P<0.001), 
as were interactions between BMI and sex and 
BMI and smoking history (P<0.001 for both).
We explored whether the association between 
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Figure 2. Hazard Ratios for Death from Cancer and 
from Atherosclerotic Cardiovascular and Respiratory 
Causes, According to BMI and Smoking History.
Data are from the KCPS, 1993–2004.12,13 The reference 
category was a BMI of 23.0 to 24.9. Results for men 
who reported having smoked cigarettes were further 
adjusted for whether the subject was a former smoker 
or a current smoker and the number of cigarettes 
smoked per day (1 to 9, 10 to 19, and 20 or more). The 
number of deaths from respiratory causes among sub-
jects with a BMI of 30.0 or more was too small to yield 
a reliable estimate of relative risks. All hazard ratios 
were adjusted for age. Panels A, B, and C have differ-
ent scales for hazard ratios in the vertical axes.
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BMI and the risk of death from atherosclerotic 
cardiovascular disease could be explained by sys-
tolic blood pressure or levels of blood glucose or 
cholesterol. As expected, adjustment for these fac-
tors attenuated this association (Table 3). Analy-
ses of death from any cause, from cancer, and 
from respiratory causes adjusted for risk factors 
are shown in Tables 3, 4, and 5, respectively, of the 
Supplementary Appendix.
Discussion
Our study confirms the findings of previous stud-
ies demonstrating that the relationship between 
death from any cause and BMI follows a J-shaped 
pattern.18 This curve reflects the association be-
tween BMI and the risk of death from all the major 
diseases. Among subjects with a low BMI, the in-
creased risk was driven by respiratory and other 
causes, whereas among those with a high BMI, it 
was associated with cancer and cardiovascular dis-
eases. Similar patterns were observed in smokers 
and those who reported never having smoked, 
implying that confounding by a history of smok-
ing cannot explain the J-shaped relationship. This 
J-shaped risk relationship has been documented 
in several of the largest, but not all, cohorts.2,11 
The patterns in the Korean, Chinese, and West-
ern1,4 cohorts appear to be similar, suggesting that 
the risk of death associated with obesity among 
Asians is not apparent at lower BMI values, as com-
pared with that among Western populations.
Because of the weight distribution of the sub-
jects, the KCPS probably contains substantially 
more information about people with lower BMI 
values than do studies with Western cohorts. At 
a BMI of less than 18.5, hazard ratios for death 
were significantly increased, with the excess due, 
in part, to respiratory causes. In the Nurses’ Health 
Study, Hu et al.5 showed that an increased risk 
in the leanest group was primarily due to an in-
crease in COPD and cirrhosis. Other studies have 
also noted a substantially increased risk of death 
among subjects with a low BMI,1,2 although they 
did not provide information about the cause of 
death. He et al.10 identified an increased risk of 
death among underweight Chinese subjects, which 
persisted after the exclusion of subjects with base-
line cardiovascular disease, cancer, renal disease, 
or COPD, and an increased risk of death during 
the first three years of follow-up. In the CPS II 
study, Calle et al.1 showed a greater increase in 
the risk of death associated with being under-
weight among those with a history of disease at 
enrollment than among those without such a his-
tory; relative risks in CPS II were similar to esti-
mates in the KCPS for BMI values of less than 
18.5. In NHANES,2 relative risks were higher over-
all (values were as high as 3.0 across the age and 
smoking strata), but analyses included subjects 
with coexisting illnesses and included deaths dur-
ing the entire follow-up period.
To reduce the potential for attributing an ex-
cess risk of being underweight to weight loss as-
sociated with illness, we excluded from all analy-
ses subjects reporting diagnoses of certain chronic 
diseases at enrollment, as well as during the first 
two years of follow-up, and we conducted sensi-
tivity analyses that excluded the first five years 
of follow-up. Although this analytic strategy may 
be effective if the illness causing rapid weight loss 
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Figure 3. Hazard Ratios for Death from Any Cause among Men and Women 
with No History of Smoking, According to Age Group and BMI.
Data are from the KCPS, 1993–2004.12,13 The reference category was a BMI 
of 23.0 to 24.9. All hazard ratios were adjusted for age. Panel A and Panel B 
have different scales for hazard ratios.
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leads to death, reverse causation may influence 
risk estimates if the disease course is lengthy and 
accompanied by weight loss.19 COPD has these 
characteristics, and subjects with more severe dis-
ease had greater weight loss over time.20 In sev-
eral studies, after adjusting for lung function, the 
BMI remained a significant predictor of death.21,22 
Thus, for COPD, the relationship between BMI 
and the risk of death may represent both reverse 
causation and a true causal role for body weight 
in determining prognosis. For tuberculosis, wast-
ing at the time of diagnosis is a feature of the dis-
ease, and body weight predicts the short-term risk 
of death.23-25 The exclusion of the first two years 
of follow-up should address any acute contribu-
tion of active tuberculosis to body weight.
Since the distribution of respiratory causes of 
death may differ between Koreans and inhab i-
tants of Western countries, it may not be possi-
ble to generalize our findings to other popula-
tions. Deaths from respiratory causes were due to 
tuberculosis in 19.3 percent of subjects, to pneu-
monia in 27.9 percent, to COPD in 27.8 percent, 
and to asthma in 24.7 percent.
For deaths from atherosclerotic cardiovas-
cular disease, the hazard ratio increased steadi-
ly with increasing BMI, similar to the findings 
in a smaller cohort study of insured Koreans.26 
Information on selected cardiovascular risk fac-
tors showed an increasingly unfavorable profile 
with increasing BMI, but these risk factors alone 
did not explain the excess risk of death from ath-
erosclerotic cardiovascular causes associated with 
obesity. Although misclassification of cardiovas-
cular risk factors, particularly those that vary dur-
ing follow-up, could partially explain the persis-
tent risk, the metabolic syndrome, sleep-disordered 
breathing, and other consequences of increased 
BMI are also likely to contribute to the risk associ-
ated with cardiovascular disease. The association 
of BMI with the risk of death from atheroscle-
rotic cardiovascular causes was substantial, as has 
been shown in many other studies.27 A few large 
cohorts provided reasonably precise estimates of 
the risk of death from cardiovascular causes ac-
cording to BMI. Similar, progressive increases in 
risk associated with BMI were seen in some stud-
ies, including the Nurses’ Health Study,5,14 non-
smokers in the Physicians’ Health Study,4 and the 
CPS I,28 but not in others, including CPS II,1 a 
U.K. cohort of particularly lean people,29 men with 
cardiovascular disease in the Physicians’ Health 
Table 3. Hazard Ratios for Death from Atherosclerotic Cardiovascular Causes, According to BMI.*
BMI Men Women
Adjusted for Age
Adjusted for 
Covariates†
Adjusted for 
Covariates and 
Intermediate 
Variables‡ Adjusted for Age
Adjusted for 
Covariates†
Adjusted for 
Covariates and 
Intermediate 
Variables‡
hazard ratio for death (95 percent confidence interval)
<18.5 0.85 (0.76–0.94) 0.78 (0.70–0.86) 1.07 (0.96–1.19) 0.86 (0.76–0.98) 0.80 (0.70–0.91) 0.97 (0.85–1.11)
18.5–19.9 0.90 (0.83–0.97) 0.85 (0.79–0.92) 1.08 (0.99–1.17) 0.90 (0.81–1.00) 0.86 (0.77–0.96) 1.00 (0.90–1.12)
20.0–21.4 0.97 (0.91–1.03) 0.93 (0.87–0.99) 1.07 (1.00–1.14) 0.96 (0.88–1.05) 0.93 (0.85–1.02) 1.02 (0.93–1.12)
21.5–22.9 0.95 (0.90–1.01) 0.93 (0.88–0.99) 1.02 (0.96–1.09) 0.94 (0.86–1.02) 0.93 (0.86–1.02) 0.98 (0.90–1.07)
23.0–24.9§ 1.00 1.00 1.00 1.00 1.00 1.00
25.0–26.4 1.04 (0.97–1.11) 1.04 (0.97–1.12) 0.98 (0.91–1.05) 1.03 (0.94–1.13) 1.03 (0.94–1.13) 0.97 (0.88–1.06)
26.5–27.9 1.13 (1.04–1.24) 1.15 (1.05–1.26) 1.02 (0.94–1.12) 1.02 (0.91–1.13) 1.02 (0.91–1.14) 0.91 (0.81–1.01)
28.0–29.9 1.32 (1.18–1.49) 1.36 (1.20–1.52) 1.09 (0.97–1.23) 1.13 (1.01–1.28) 1.15 (1.02–1.30) 0.99 (0.88–1.12)
30.0–31.9 1.58 (1.29–1.95) 1.58 (1.28–1.95) 1.21 (0.98–1.50) 1.31 (1.09–1.57) 1.33 (1.11–1.59) 1.08 (0.90–1.30)
≥32.0 2.75 (1.98–3.82) 2.86 (2.05–3.97) 1.94 (1.39–2.71) 1.28 (1.01–1.62) 1.30 (1.02–1.65) 1.04 (0.82–1.32)
* Data are from the KCPS, 1993–2004.12,13
† Covariates are age (continuous); cigarette smoking, including status (never smoked, former smoker, or current smoker) for both sexes and 
the number of cigarettes smoked per day (1 to 9, 10 to 19, or ≥20) for men, alcohol intake (0, 1 to 24, 25 to 49, 50 to 99, or at least 100 g 
per day for men and 0 g per day or any intake for women), and level of participation in physical exercise.
‡ Intermediate variables are fasting blood glucose levels, systolic blood pressure, and serum cholesterol levels (all continuous).
§ This group served as the reference group.
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Study,30 and a representative sample of Chinese 
men and women.11 
The risk of death from cancer increased slight-
ly among overweight men and women and more 
substantially among subjects with a BMI above 
30.0 at enrollment; we observed no excess risk 
among subjects who had a low BMI at enrollment. 
In a meta-analysis by McGee,27 pooled estimates 
of the risk of death from cancer that compared 
obese subjects with those of normal weight were 
much smaller — 1.10 for women and 1.06 for men 
— than in our study. The Nurses’ Health Study 
reported risks similar to those in our study, but 
risks in similar BMI strata were lower in CPS I 
and II.1,31 Distributions of deaths according to 
the type of the primary tumor differ between Ko-
rean and U.S. populations.32 Nonetheless, our 
findings indicate that obesity does contribute to 
Korea’s cancer burden.
As has been reported in other populations, we 
found that the association between BMI and the 
risk of death varied according to age, with little 
evidence of increased risk among obese subjects 
over the age of 65 years. This effect modification 
has been the subject of controversy because BMI 
is less well correlated with adiposity in the el-
derly and because of the increased probability of 
undiagnosed diseases and survivor effects in this 
age group.33 Substantial interest exists, however, 
in conducting an estimation of the future burden 
of obesity as today’s obese children and young 
adults grow older.2,34,35 In other studies, investi-
gators showed that an older age at enrollment 
(the variable used in our analysis) attenuated the 
risk associated with obesity.28,36 In fact, in CPS I, 
overweight and obesity were not associated with 
an increased risk of death among subjects older 
than 85 years.28 In a recent report by Flegal et al.2 
of follow-up data from NHANES I, II, and III, 
subjects in the oldest age group (70 years or 
older) who had a BMI of more than 25 were not 
at increased risk for death. Our evidence pro-
vides support for this modification of effect by 
age, but this effect has not been observed in all 
populations.4
The association of BMI in the overweight and 
obese range with an increased risk of death from 
atherosclerotic cardiovascular causes and cancer 
suggests that control of excess adiposity may re-
duce the two most important causes of death 
among Koreans. The inverse association between 
BMI and the risk of death from respiratory causes 
partly explains the J-shaped relationship between 
BMI and the risk of death from any cause, but 
further research is warranted to examine the ex-
tent of reverse causation and to consider the role 
of other causes of an increased risk of death in 
association with a low BMI.
In considering whether the findings of the 
KCPS can be applied to other populations, we 
recognize that Asian populations generally have 
a higher percentage of body fat than do Western 
populations at the same BMI level.7 In a meta-
analysis of the predictive ability of BMI to esti-
mate the percentage of body fat among various 
ethnic groups, Deurenberg et al.6 found that for 
the same percentage of body fat, BMI among sub-
jects from various East Asian countries was lower 
by 1.9 to 3.2 than that of white subjects. Although 
contributing factors are not completely under-
stood,7 Asians generally have a slighter body build 
than do whites, and slighter people tend to have 
less muscle mass and connective tissue.37 Conse-
quently, the WHO recommends that cutoff val-
ues in the definition of overweight and obesity 
should be lower for Asian populations than for 
Western populations.7,38 Our observations may 
prove to be useful in the evaluation of this rec-
ommendation.
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